Aspen API. More than just an API™
01 1Aspen Oss B.V.
01 1Rimexolone
01 1Netherlands
Aspen API. More than just an API™
NDC Package Code : 60870-0423
Start Marketing Date : 1997-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
41
PharmaCompass offers a list of Rimexolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rimexolone manufacturer or Rimexolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rimexolone manufacturer or Rimexolone supplier.
PharmaCompass also assists you with knowing the Rimexolone API Price utilized in the formulation of products. Rimexolone API Price is not always fixed or binding as the Rimexolone Price is obtained through a variety of data sources. The Rimexolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vexol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vexol, including repackagers and relabelers. The FDA regulates Vexol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vexol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vexol supplier is an individual or a company that provides Vexol active pharmaceutical ingredient (API) or Vexol finished formulations upon request. The Vexol suppliers may include Vexol API manufacturers, exporters, distributors and traders.
click here to find a list of Vexol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vexol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vexol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vexol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vexol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vexol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vexol suppliers with NDC on PharmaCompass.
